XJTLU-PegBio Chronic Disease Research Institute
XJTLU-PegBio Chronic Disease Research Institute was jointly established by XJTLU Wisdom Lake Academy of Pharmacy and PegBio Biomedical (Suzhou) to focus on drug metabolism and neurodegenerative disease research and development. With support from the Academy, the institute aims to build a world-class research and development platform in innovative drugs for chronic disease, leading to premium-quality medicines that benefit the majority of patients and promote the Pharma Valley of China’s industrial development.
The institute will connect top talents in innovative chronic-disease drugs research and development, develop and commercialise cutting-edge innovative drugs for chronic diseases, and cultivate international talents for emerging industries.
XJTLU Wisdom Lake Academy of Pharmacy-BEAVER Biomedical Joint Research Lab
XJTLU Wisdom Lake Academy of Pharmacy-BEAVER Biomedical Joint Scientific Laboratory was co-founded by the Academy and BEAVER Biomedical Engineering. Its focus is the application and development of nanomaterials in biopharmaceuticals, mainly the application of nanomaterials in biological sample culture, separation, purification and detection. The lab aims to link high-end talents and contribute to research and development of key technology, commercialisation of scientific and technological achievements, and implementation of smart application solutions.
Academy of Pharmacy-Convergen Joint Research Lab
XJTLU Wisdom Lake Academy of Pharmacy and Convergen (Suzhou) Pharmaceutical have established a joint scientific laboratory to explore potential therapeutic targets in the field of innovative drug research and development for anti-tumour and immune disease treatment. They will exchange information on technology and policy, seek out and cultivate talents together, and jointly carry out scientific research projects.
